Cyclo(CRVIIF) | MedChemExpress (MCE)
Cyclo CRVIIF is a dual inhibitor for hypoxia inducible factor (HIF) 1 and 2, which disrupts the interaction of both HIF1-α and HIF2-α with HIF1-β, with affinity for HIF1-α and HIF2-α PAS-B domains KD of 65 and 123 μM, respectively[1].
Trivial name | Cyclo(CRVIIF) |
Catalog Number | HY-P10223 |
Research Area | Cancer |
Purity | ≥98.0% |
SMILES | O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@@H](C)CC)C(N[C@H]1CC2=CC=CC=C2)=O)=O)=O)=O)[C@H](CS)NC1=O |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/cyclo-crviif.html |